Marek R.
- Country
- Poland
- Department
- Poradnia Internistyczn
Research Overview
- Long-Term Extension Study of Imeroprubart in Adult Patients With Graves' Disease
- Open-Label Rollover Study of AMG 732 in Thyroid Eye Disease Nonresponders and Relapsed Participants
- Evaluation of Batoclimab Efficacy and Safety in an Open-Label Extension Study for Thyroid Eye Disease Treatment in Participants Completing IMVT-1401-3201/3202
Data & Insights
Has run more than one trial at 98 of 234 partner sites.
Specializations
Endocrine Disorders
The investigator specializes in treating complex endocrine conditions, with particular emphasis on acromegaly management and innovative therapeutic approaches.
- Growth hormone regulation disorders
- Novel oral therapeutic solutions
- IGF-1 response monitoring
Active involvement in evaluating emerging treatments for patients with uncontrolled acromegaly.
Rare Endocrine Conditions
Focused expertise in treating Classic Congenital Adrenal Hyperplasia (CAH) and adrenocortical carcinoma, exploring innovative therapeutic approaches.
- Glucocorticoid optimization
- Adrenal steroid management
- Advanced cancer therapeutics
Specializes in developing treatment strategies for rare endocrine disorders with limited therapeutic options.
Autoimmune Eye Disorders
Expert in managing Thyroid Eye Disease (TED), investigating novel biological therapies for improved patient outcomes.
- Proptosis management
- Long-term disease control
- Innovative antibody treatments
Dedicated to advancing treatment options for patients with active thyroid eye disease.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.